Sum­it­o­mo’s over­ac­tive blad­der drug adds an­oth­er in­di­ca­tion

Sum­it­o­mo Phar­ma’s oral treat­ment for over­ac­tive blad­der symp­toms won an ex­pand­ed la­bel from the FDA, and is now ap­proved to treat men who are si­mul­ta­ne­ous­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER